IL6 and COVID-19: We found that EVs from severely ill COVID‐19 patients enriched with members of the TNF superfamily and their receptors, IL‐6‐family proteins, IFN‐γ‐inducible chemokines and IL‐1‐family proteins can clearly distinguish COVID‐19 patients with severe disease from patients with moderate or mild disease.